{"url":"https://lda.senate.gov/api/v1/filings/43c202e4-e31f-4455-b648-e695e999e53d/","filing_uuid":"43c202e4-e31f-4455-b648-e695e999e53d","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2022,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/43c202e4-e31f-4455-b648-e695e999e53d/print/","filing_document_content_type":"text/html","income":"80000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Richard M. Gold, Partner","dt_posted":"2022-04-20T17:00:06-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"800 17th Street, NW, Suite 1100","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20006","registrant":{"id":18466,"url":"https://lda.senate.gov/api/v1/registrants/18466/","house_registrant_id":30825,"name":"HOLLAND & KNIGHT LLP","description":"Law Firm","address_1":"800 17th Street NW","address_2":"Suite 1100","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20006","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"RICHARD GOLD","contact_telephone":"+1 202-955-3000","dt_updated":"2026-01-29T12:53:12.839213-05:00"},"client":{"id":125377,"url":"https://lda.senate.gov/api/v1/clients/125377/","client_id":1007375,"name":"PUBLIC ACCESS TO SUNSCREENS (PASS) COALITION","general_description":"Informal coalition of health and consumer organizations and sunscreen industry companies","client_government_entity":false,"client_self_select":false,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":null,"ppb_state_display":null,"ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2013-03-14"},"lobbying_activities":[{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Implementation of the over the counter drug approval process reforms for sunscreen ingredients included in Public Law 116-136, the Coronavirus Aid, Relief, and Economic Secretary (CARES Act); issues related to sunscreen use and coral reefs; National Academies of Sciences study on sunscreen; FDA draft environmental impact statement regarding sunscreen; FDA proposed order on over-the-counter sunscreen ingredients; FY 2022 House and Senate appropriations for the Food and Drug Administration (H.R. 4356 and S. 2599); FY 2023 House and Senate appropriations for the Food and Drug Administration.","foreign_entity_issues":"As the parent entity of Beiersdorf Inc., Beiersdorf AG, headquartered in Germany, has a general interest in the lobbying issues.","lobbyists":[{"lobbyist":{"id":30400,"prefix":"mr","prefix_display":"MR.","first_name":"RICHARD","nickname":null,"middle_name":"M","last_name":"GOLD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":38757,"prefix":null,"prefix_display":null,"first_name":"JOEL","nickname":null,"middle_name":null,"last_name":"ROBERSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":47502,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"WERNER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":65579,"prefix":null,"prefix_display":null,"first_name":"ETHAN","nickname":null,"middle_name":null,"last_name":"JORGENSEN-EARP","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}